KRAS and neoplasm: As Kras mutations increase pro-inflammatory pathways that alter the tumor microenvironment and contribute to tumor progression54, we used flow cytometry (gating strategy shown in Supplemental Fig. 6) and IHC to investigate immune cell populations in the lungs of the A/J mice treated with rexinoids.